NBTX Nanobiotix Corp: Bathi saben siji saham sajrone 12 wulan pungkasan

Simbol resmi perusahaan Nanobiotix SA (NBTX)

The development of Nanobiotix S.A. (NBTX) is tied to regulatory approvals and the pursuit of capital. The year-over-year EPS (TTM) trend captures these financial fluctuations, where the -58.80 level serves as a critical benchmark. The integration of nanoparticles into standard therapy promises a steady revenue stream, while management's flexible strategy in partnership with a pharma behemoth increases the likelihood of successful clinical trials.

Nanobiotix S.A. (NBTX) - Bathi resik saben saham (EPS TTM) saka 11.02.2024 nganti 18.11.2026

Nanobiotix Corp - rincian analitis lan metrik utama (NBTX)

- data kapitalisasi saham perusahaan:
Analisis wiwitan perusahaan:NBTX, Nanobiotix SA
Produk sing diprodhuksi Nanobiotix SA

This indicator measures the dynamics of net earnings per share over a rolling year, neutralizing quarterly gaps and capturing the business's operational response to market changes. For Nanobiotix S.A. (NBTX), which depends on FDA/EMA approvals and currently lacks active patients, the YoY change in EPS on a rolling 12-month basis serves as a marker of financial stability during the pre-commercialization phase supported by J&J.